Integral Diagnostics Limited (ASX:IDX)
Australia flag Australia · Delayed Price · Currency is AUD
1.620
-0.030 (-1.82%)
Nov 17, 2026, 11:20 AM AEDT

Integral Diagnostics Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Integral Diagnostics stock has a consensus rating of "Buy" and an average price target of $2.51. The average 1-year stock price forecast is 54.63% higher than the current stock price, while the lowest is $1.77 (+9.26%) and the highest is $3.30 (+103.70%).

Price Target: $2.51 (+54.63%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$1.77$2.51$2.70$3.30
Change+9.26%+54.63%+66.67%+103.70%

Analyst Ratings

The average analyst rating for Integral Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy888877
Buy444322
Hold112244
Sell000000
Strong Sell000000
Total131314131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Hold
Downgrades
$1.77
HoldDowngrades$1.77+9.26%Nov 3, 2026
Jefferies
Jefferies
Buy
Maintains
$3.30 → $2.90
BuyMaintains$3.30 → $2.90+79.01%Oct 30, 2026
Unknown Analyst
Goldman Sachs
No rating
Goldman Sachs
Hold
Maintains
$2.24 → $1.82
HoldMaintains$2.24 → $1.82+12.35%Oct 30, 2026
Ord Minnett
Ord Minnett
Buy
Maintains
$3.30 → $2.70
BuyMaintains$3.30 → $2.70+66.67%Oct 30, 2026
RBC Capital
RBC Capital
Buy
Maintains
$3.20 → $2.80
BuyMaintains$3.20 → $2.80+72.84%Oct 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
824.75M
from 788.62M
Increased by 4.58%
Revenue Next Year
869.93M
from 824.75M
Increased by 5.48%
EPS This Year
0.11
from 0.13
Decreased by -14.61%
EPS Next Year
0.13
from 0.11
Increased by 21.61%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
360.93M440.76M469.70M627.22M788.62M824.75M
Revenue Growth
2.92%22.12%6.57%33.54%25.73%4.58%
Gross Profit
122.10M142.43M151.90M195.98M243.36M280.42M
Gross Margin
33.83%32.31%32.34%31.25%30.86%34.00%
Operating Income
38.62M38.47M42.17M56.80M73.84M88.93M
Net Income
14.60M25.04M-60.70M2.69M21.93M34.26M
EPS
----0.130.11
EPS Growth
----23.53%-14.61%
Forward PE
17.4225.9927.6720.3213.7715.06
Dividend / Share
0.070.060.060.070.090.08
Dividend Growth
-44.00%-14.29%-3.33%12.07%43.08%-17.52%
Free Cash Flow
----45.60M56.95M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High833.8M
Avg824.8M
Low821.2M

Revenue Growth

Revenue Growth202720282029
High
5.7%
Avg
4.6%
Low
4.1%

EPS Forecast

EPS202720282029
High0.14
Avg0.11
Low0.10

EPS Growth

EPS Growth202720282029
High
10.6%
Avg
-14.6%
Low
-20.6%